Comparison of oral versus parenteral methotrexate in the treatment of rheumatoid arthritis: A meta-analysis.

Parenteral MTX therapy had significantly higher odds than oral MTX of achieving reduction in disease activity. We propose that parenteral MTX is more effective than weekly oral MTX; its widespread use may lead to better control of disease and a decrease in demand for biologic agents.